Pfizer (PFE) Market Capitalization (2009 - 2026)

Pfizer (PFE) Market Capitalization (2009 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn
10 Novartis Ag 109.78 Bn 109.09 Bn -

Historic Data

Download Data
DateValue
Jun 5, 2026 148.19 Bn
Jun 4, 2026 146.20 Bn
Jun 3, 2026 144.21 Bn
Jun 2, 2026 145.41 Bn
Jun 1, 2026 145.86 Bn
May 29, 2026 148.99 Bn
May 28, 2026 148.76 Bn
May 27, 2026 149.16 Bn
May 26, 2026 146.76 Bn
May 22, 2026 147.40 Bn
May 21, 2026 147.54 Bn
May 20, 2026 147.14 Bn
May 19, 2026 146.17 Bn
May 18, 2026 143.93 Bn
May 15, 2026 144.15 Bn
May 14, 2026 146.43 Bn
May 13, 2026 147.74 Bn
May 12, 2026 147.23 Bn
May 11, 2026 146.88 Bn
May 8, 2026 146.14 Bn